Advertisement

Topics

Search Results for "Crossbar Array"

06:40 EDT 26th May 2016 | BioPortfolio

Matching Channels

UGenRA - Genitourinary cancer array

UGenRA is a CGI custom-designed oligonucleotide array designed to detect gains and losses of genomic material in endometrial, ovarian, and cervical cancers. Endometrial hyperplasia is a precursor le...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It...

MatBA - Mature B-cell neoplasm array

Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genet...

GMO Crops - news, views, reports

Transgenic plants have been engineered to possess several desirable traits, such as resistance to pests, herbicides, or harsh environmental conditions, improved product shelf life, and increased nut...

Matching News

License Agreement: Array Biopharma, $ARRY (Loxo Oncology, $LOXO)

July 2013, Array BioPharma (ARRY) entered into a Drug Discovery Collaboration Agreement with Loxo Oncology (LOXO) @LoxoOncology, and granted Loxo exclusive rights to develop and commercialize certain ...

UK to Unveil Largest Floating Solar Array in the World

Workers with Ennoviga Solar and Lightsource Renewable Energy are set to unveil the largest floating solar array in the world, later this month. The five-year project was commissioned by Thames Water a...

Array BioPharma, Pierre Fabre In Oncology Alliance

To develop Array's late-stage products, binimetinib and encorafenib

License Agreement: Array BioPharma, $ARRY (Oncothyreon, $ONTY)

May 2013 Array BioPharma (ARRY) entered into a Development and Commercialization Agreement with Oncothyreon (ONTY) to collaborate on development and commercialization of ONT380 for the treatment of ca...

Array BioPharma closes cancer drug deal with Pierre Fabre

Array may receive up to US$425m in agreement to develop novel oncology products

Array's Binimetinib meets primary endpoint in Phase III trials

Shares in US company Array Biopharma (Nasdaq: ARRY) rose by nearly a third after it was announced the…

Array BioPharma and Pierre Fabre team up for oncology products

Array BioPharma and Pierre Fabre have announced a collaboration to globally develop and commercialise Array's late-stage novel oncology products, binimetinib and encorafenib

Array BioPharma, Asahi Kasei Pharma collaborate for novel pain and inflammation program

Array BioPharma and Asahi Kasei Pharma announced a strategic collaboration to develop and commercialize select Tropomyosin receptor kinase A (TrkA) inhibitors, including Array-invented ARRY-954, for p...

Matching PubMed Articles

Three-Dimensional Networked Nanoporous Ta2O5-x Memory System for Ultrahigh Density Storage.

Oxide-based resistive memory systems have high near-term promise for use in nonvolatile memory. Here we introduce a memory system employing a three-dimensional (3D) networked nanoporous (NP) Ta2O5-x s...

High-level integration of three-dimensional microcoils array in fused silica.

Rapid and facile creation of three-dimensional (3D) microcoils array in a "lab-on-a-chip" platform is a big challenge in micromachining. Here we report a method based on an improved femtosecond-laser ...

Feature Extraction Using Memristor Networks.

Crossbar arrays of memristive elements are investigated for the implementation of dictionary learning and sparse coding of natural images. A winner-take-all training algorithm, in conjunction with Oja...

Piezo-Phototronic Enhanced UV Sensing Based on a Nanowire Photodetector Array.

A large array of Schottky UV photodetectors (PDs) based on vertical aligned ZnO nanowires is achieved. By introducing the piezo-phototronic effect, the performance of the PD array is enhanced up to se...

Confirmation rates of array-CGH in day-3 embryo and blastocyst biopsies for preimplantation genetic screening.

The purpose of this study was to compare the confirmation rate of day-3 embryo biopsy (blastomere) and trophectoderm biopsy using array-comparative genomic hybridization (array-CGH) technology.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement